Mesoblast Quote - MSB

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

3.14

Bid

3.16

Ask

3.17

Volume

7,911,122

2.98 Day's Range 3.17

0.255 52 Week Range 3.37

Market Cap

2.313B

Previous Close

3.05

Open

3.12

Last Trade

50000

3.17

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

8,412,977

Shares Outstanding

736,578,315

Dividend Yield

PE Ratio

-26.30

Earnings Per Share (EPS)

-0.12

Revenue

9.25M

Net Profit

-87.96M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.mesoblast.com

Headquarters

Melbourne, Victoria, Aus

Founded

Mesoblast Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker MSB. The last closing price for Mesoblast was AUD3.05. Over the last year, Mesoblast shares have traded in a share price range of AUD 0.255 to AUD 3.37.

Mesoblast currently has 736,578,315 shares outstanding. The market capitalization of Mesoblast is AUD2.25 billion. Mesoblast has a price to earnings ratio (PE ratio) of -26.30.

Mesoblast Gets FDA's Special Pediatric Designation for Revascor Heart Treatment

By Dean Seal Mesoblast said regulators have granted their rare pediatric disease designation to its cell therapy Revascor for children with hypoplastic left heart syndrome. The Australian...

Mesoblast ADSs Plunge Premarket on Latest FDA Rejection

By Colin Kellaher American depositary shares of Mesoblast plummeted more than 65% in premarket trading Friday after the biopharmaceutical company's latest setback in its bid to win U.S. Food...

FDA Schedules Pre-License Inspection of Remestemcel-L Manufacturing

Biologics License Application (BLA) Resubmission for Pediatric Acute Graft-Versus-Host Disease (SR-aGVHD) Currently Being Reviewed PDUFA Goal Date August 2, 2023 If Approved, Remestemcel-L will be...

Mesoblast ADSs Rally as FDA Accepts Remestemcel-L Resubmission

By Colin Kellaher American depositary shares of Mesoblast Ltd. jumped more than 15% in early trading Wednesday after the biopharmaceutical company said the U.S. Food and Drug Administration...

Mesoblast Shares Rise 11% After Resubmitting Biologics License Application

By Chris Wack Mesoblast Ltd. shares were up 11% to $3.67 Wednesday after the company said it resubmitted a biologics license application to the U.S. Food and Drug Administration seeking approval...

Mesoblast Shares Rise 10% After New Info Submitted to FDA for Remestemcel-L

By Chris Wack Mesoblast Ltd. shares were up 10% to $2.80 after the company said it submitted substantial new information to the U.S. Food and Drug Administration on clinical and potency assay...

Mesoblast to Hold Type C Meeting With FDA for Back Pain Treatment

By Chris Wack Mesoblast Ltd. said it has filed a request and expects to hold a Type C meeting with the U.S. Food & Drug Administration during the current quarter to discuss the pathway to U.S...

Mesoblast Up 25% After Hours on Collaboration With Novartis

By Josh Beckerman Mesoblast Ltd. American depositary receipts surged 25% to $14.70 after hours as the company entered an exclusive worldwide license and collaboration agreement with Novartis AG...

Mesoblast Named Global Technology Leader in Cell Therapy Industry

Mesoblast Limited has been named by Frost & Sullivan as the 2017 Global Technology Leader in the Cell Therapy Industry. Mesoblast is a biopharma company specializing in cell...

Mesoblast’s Japan Licensee Receives Pricing for TEMCELL® HS Inj. for Treatment of Acute Graft Versus Host Disease

MELBOURNE, Australia and NEW YORK, Nov. 27, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) today announced that its licensee in Japan, JCR Pharmaceuticals Co. Ltd., has...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.35	12.5448028674	2.79	3.17	2.72	5460581	2.90777869	DE
4	-0.01	-0.31746031746	3.15	3.37	2.54	7058636	2.90401305	DE
12	1.795	133.457249071	1.345	3.37	1.33	8412977	2.36517716	DE
26	2.095	200.4784689	1.045	3.37	0.88	6183441	1.85629238	DE
52	2.87	1062.96296296	0.27	3.37	0.255	7617251	1.26030433	DE
156	2.045	186.757990868	1.095	3.37	0.255	4199005	1.04040363	DE
260	0.14	4.66666666667	3	5.7	0.255	4623454	1.96479547	DE

MSB - Frequently Asked Questions (FAQ)

What is the current Mesoblast share price?

The current share price of Mesoblast is AUD 3.14

How many Mesoblast shares are in issue?

Mesoblast has 736,578,315 shares in issue

What is the market cap of Mesoblast?

The market capitalisation of Mesoblast is AUD 2.25B

What is the 1 year trading range for Mesoblast share price?

Mesoblast has traded in the range of AUD 0.255 to AUD 3.37 during the past year

What is the PE ratio of Mesoblast?

The price to earnings ratio of Mesoblast is -26.3

What is the cash to sales ratio of Mesoblast?

The cash to sales ratio of Mesoblast is 249.21

What is the reporting currency for Mesoblast?

Mesoblast reports financial results in USD

What is the latest annual turnover for Mesoblast?

The latest annual turnover of Mesoblast is USD 9.25M

What is the latest annual profit for Mesoblast?

The latest annual profit of Mesoblast is USD -87.96M

What is the registered address of Mesoblast?

The registered address for Mesoblast is LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, 3000

What is the Mesoblast website address?

The website address for Mesoblast is www.mesoblast.com

Which industry sector does Mesoblast operate in?

Mesoblast operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CR3ODCore Energy Minerals Ltd	AUD 0.003 (200.00%)	3.57M
NAGONagambie Resources Limited	AUD 0.002 (100.00%)	550k
NRZONeuRizer Ltd	AUD 0.003 (50.00%)	6.13k
EELENRG Elements Ltd	AUD 0.0015 (50.00%)	21.49k
MVPMedical Developments International Limited	AUD 0.645 (48.28%)	1.42M
ATHOAlterity Therapeutics Limited	AUD 0.007 (-41.67%)	46.52M
ATHAlterity Therapeutics Ltd	AUD 0.0115 (-36.11%)	123.58M
BDTBirdDog Technology Ltd	AUD 0.037 (-33.93%)	7.86M
NRZNeuRizer Ltd	AUD 0.002 (-33.33%)	5.92M
MGUOMagnum Mining and Exploration Ltd	AUD 0.002 (-33.33%)	1.14M
ATHAlterity Therapeutics Ltd	AUD 0.0115 (-36.11%)	123.58M
VAUVault Minerals Ltd	AUD 0.385 (5.48%)	49.45M
ATHOAlterity Therapeutics Limited	AUD 0.007 (-41.67%)	46.52M
SYASayona Mining Limited	AUD 0.023 (4.55%)	42.72M
LOTLotus Resources Limited	AUD 0.25 (6.38%)	42.53M